Cellectis (CLLS) Net Income towards Common Stockholders (2015 - 2026)

Cellectis' Net Income towards Common Stockholders history runs 12 years deep, the most recent figure standing at -$0.18 for Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders changed 0.0% year-over-year to -$0.18 in Q1 2026; TTM through Mar 2026 was -$23.1 million, a 45.41% increase from a year earlier, with the FY2025 full-year figure at -$0.67, up 100.0% from the prior year.
• Net Income towards Common Stockholders rose to -$0.18 in Q1 2026 per CLLS's latest filing, from -$0.26 in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $5.9 million in Q4 2024 and bottomed at -$41.8 million in Q4 2023.
• The 5-year median for Net Income towards Common Stockholders is -$18.9 million (2022), against an average of -$15.7 million.
• Across the five-year window, Net Income towards Common Stockholders plunged 168.88% in 2022 and jumped 118.76% in 2024, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$26.8 million in 2022, then tumbled by 55.86% to -$41.8 million in 2023, then soared by 114.17% to $5.9 million in 2024, then plunged by 100.0% to -$0.26 in 2025, then jumped by 30.77% to -$0.18 in 2026.
• Per Business Quant, the three latest CLLS Net Income towards Common Stockholders figures stand at -$0.18 (Q1 2026), -$0.26 (Q4 2025), and $589000.0 (Q3 2025).